Interim report quarter 2 - Continued Efemia market expansion with Germany in sight
SECOND QUARTER (April - June 2019) · The company’s sales amounted to 101 (0) KSEK. · Work capitalised by the company for its own use amounted to 0 (187) KSEK. · Operating costs amounted to 3,243 (2,043) KSEK. · Result after tax amounted to -3,143 (-1,857) KSEK. · Result per share amounted to -0.30 (-0.19) SEK. CEO Karin Bryder summarizes the quarter During the second quarter of 2019, we continued to focus on establishing and marketing Invent Medic’s first product Efemia Bladder Support in Sweden, the Nordic region and Europe. The marketing activities are targeting